Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.
| Price |
Change |
% Change |
Volume |
Day High/Low |
52 Week High/Low |
|
|
|
|
|
|
post
threaded view
| subject | user |
date & time |
rating |
|
With the press release today, there's a squeeze happening with the ALNY short-sellers. Volume has hit approximately 3.5 million today. Over 5 million ALNY shares had been shorted as of June 30th. They're all trying to cover their short... |
|
7/16/2012 12:27:08 PM |
|
|
post
threaded view
Stockhouse.com: Taking
it to the street
